Rua Notice of 2024 Annual Shareholders' Meeting
MEETING ANNOUNCEMENT
NZX:RUA
Thursday 17 October 2024
Rua Bioscience Limited 2024 Annual Shareholders Meeting
The 2024 Annual Meeting of Rua Bioscience Limited (Rua) will be held virtually via
Computershare’s online meeting platform at https://meetnow.global/nz at 10.00am (New Zealand
time) on Monday, 4 November 2024.
Attached is the Notice of Meeting, which includes details for proxy voting, the online meeting
details and the resolutions for shareholder consideration.
ENDS
For more information, please visit www.ruabio.com or contact:
Paul Naske
Chief Executive Officer
+64 (21) 445 154
www.ruabio.com
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
---
1
Notice of 2024 Annual Shareholder Meeting
1
Notice of Annual Meeting of Shareholders
17
th
October 2024
Dear Shareholder,
The 2024 Annual Meeting of Rua Bioscience Limited (Rua) will be held virtually via Computershare’s
online meeting platform at https://meetnow.global/nz at 10.00am (New Zealand time) on Monday, 4
November 2024.
We have decided to again hold a virtual‐only meeting this year as that format is logistically more
straightforward and less expensive. In addition, following the meeting we will be conducting a
community engagement day on November 5
th
at our facility at Ruatorea where so many of our
shareholders reside. This will provide investors with the opportunity to meet and interact with
members of the Board and Management. For further details about the meeting please go to
www.ruabio.com or our social media channels.
When participating online, shareholders will require their shareholder number, found on the enclosed
proxy form for verification purposes. Details on how to participate online are set out below under the
heading “Online Participation Details”.
Items of Business
1. Company Overview
2. Chair’s Address
3. Chief Executive’s Presentation
4. Annual Results Presentation
5. Shareholder Questions
5.1. To consider any shareholder questions submitted to the Annual Meeting (to the extent these
questions have not already been addressed in the Chair’s Address, the Chief Executive
Officer’s Presentation or the Annual Results Presentation).
For further details, see Explanatory Note 1.
6. Ordinary Resolution 1 –
Auditors Remuneration
6.1. To consider and, if thought fit, pass the following Ordinary Resolution, requiring approval by
a simple majority of the votes of shareholders entitled to vote and voting:
6.1.1. That the Board be authorised to fix the auditor’s remuneration.
For further details, see Explanatory Note 2.
2
7. Ordinary Resolution 2 – Approval of Issue of New Ordinary Shares
7.1. To consider and, if thought fit, pass the following Ordinary Resolution, requiring approval by
a simple majority of the votes of shareholders entitled to vote and voting:
7.1.1. That the Directors are authorised to issue up to 37,311,522
new ordinary fully paid
shares in the Company (New Shares) on the following terms:
(a) The New Shares may be issued to any person subject to the Company
complying with the requirements of the Financial Markets Conduct Act 2013
and the NZX Listing Rules in relation to any such
issue.
(b) The New Shares may be issued through a single placement of up to
37,311,522 New Shares or via separate placements of up to 37,311,522 New
Shares in aggregate.
(c) Each New Share shall be issued at an issue price of not less than $0.03.
(d) The New Shares may
be issued at any time during the course of the 12 month
period following the passing of this resolution.
(e) The New Shares, when issued, shall rank pari passu (equally) with all existing
ordinary shares in the Company.
For further details, see Explanatory Note 3.
8. General Business
8.1. To
consider any other business that can be properly brought before the meeting.
Further Information and Explanatory Notes
Further information relating to the resolutions is set out in the Explanatory Notes accompanying this
Notice of Meeting. Please read and consider the resolutions together with the Explanatory Notes.
Online Participation Details
All shareholders
will have the opportunity to attend the Annual Meeting online through the
Computershare Meeting Platform using a computer, laptop, tablet or smartphone – simply visit
https://meetnow.global/nz and follow the prompts under the ‘Rua Bioscience Limited Annual
Meeting’ icon.
Your browser will need to be compatible with the latest version of Chrome, Safari or Edge. If you are
a shareholder, you will also need your CSN/Securityholder Number, which can be found on your proxy
form or email invitation (where applicable).
Shareholders will be able to view the
presentations on their selected devices. Audio will stream
through your selected device, so please ensure that the volume control on your headphones or device
is turned up. Instructions on how to participate ‘virtually’ are provided in the Virtual Meeting Guide
available at www.computershare.com/vm‐guide‐nz.
Shareholders will be able to vote
on the resolutions to be put to shareholders and will have the ability
to ask questions on their selected devices. Shareholders will still be able to appoint a proxy to vote for
them, as they otherwise would, by following the instructions on the proxy form and in this Notice of
Annual Meeting. If you have any questions on, or need assistance with, the online process, please
3
contact Computershare on +64 9 488 8777 between 8.30am and 5.00pm (New Zealand time) Monday
to Friday
Attendance and Voting
Your rights to vote may be exercised by:
(a)Voting at the virtual meeting and casting your vote via the Computershare Online Meeting
Platform at https://meetnow.global/nz during the meeting. Instructions for how to do this is
included in the Virtual Meeting Guide; or
(b)Appointing a proxy (or representative) to attend and vote in your place. The proxy need not
be a shareholder of Rua and the form of appointment of a proxy and voting instructions
accompany this Notice of Meeting. You can appoint a proxy online or complete and send the
Proxy Voting Form (enclosed with this Notice of Meeting) by post, email (as a scanned
attachment) so that it is received by Computershare by no later than 10.00am on Saturday 2
November 2024.
I look forward to seeing you at the Annual Meeting and thank you for your ongoing support.
By order of the Board.
Anna Stove
Chair
17
th
October 2024
4
Explanatory Notes
Note 1 – Shareholder Questions
Shareholders may submit written questions to be considered at the Annual Meeting. Written
questions should be sent by email to paul.naske@ruabio.com with the reference to “Annual Meeting”
in the subject line or by post to “Annual Meeting”, Rua Bioscience Limited, 1 Commerce Place,
Awapuni, Gisborne 4071.
Rua reserves the right not to address any questions that, in the Board’s
opinion, are not reasonable to address in the context of an annual meeting.
Note 2‐ Auditor’s Remuneration
Ordinary Resolution 1
PricewaterhouseCoopers is automatically reappointed as auditor under section 207T of the
Companies Act 1993. Under section 207S
of the Companies Act 1993, the auditor’s fees and expenses
must be fixed in the manner that is determined at the annual meeting of the Company. This resolution
therefore authorises the Board to fix the fees and expenses of PricewaterhouseCoopers as the
Company’s auditor for the current financial year.
Note 3
– Approval of issue of new ordinary shares
Ordinary Resolution 2
The Directors wish to seek the approval of shareholders to enable them to issue up to a further
37,311,522 new fully paid ordinary shares in the Company (New Shares) to assist with ongoing funding
requirements of the Company,
including scaling its sales efforts in key international markets,
particularly Germany, Australia and UK. The New Shares will be the same class of shares as the existing
ordinary shares on issue in the Company.
The Company’s 2024 Annual Report (Annual Report) stated:
“Given the Group’s net operating loss of $13,718,754
and net operating cash outflow of $3,736,479
for the year ended 30 June 2024, in addition to its reduced liquid net asset position, the Board and
management have prepared cash flow forecasts for the next 12 months. These indicated that the
Group will not have sufficient cash to meet its
minimum expenditure commitments and support its
current levels of activity without undertaking additional action.”
In addition to a property sale referred to in the Annual Report (see note 2.(f)(i)), Ordinary Resolution
2 forms part of the Company’s actions to ensure it meets its going concern assumption.
Each New Share would have
an issue price of not less than $0.03. An issue price of $0.03 represents
a 36% discount to the Volume Weighted Average Price (VWAP) of the Company’s shares traded on
the NZX during the 20 trading days up to the 15th October 2024. The expectation would be that the
Board would seek to issue the New Shares at a share price that is no more than a 36% discount to the
prevailing current market price for the Company’s shares at the time of issue of the New Shares.
The New Shares would be required to be issued within 12 months
from the date that shareholders
resolve to approve the issue of the New Shares. If any New Shares are not issued within this
timeframe, the approval to issue those New Shares would lapse.
The purpose of seeking approval to potentially issue the New Shares would be to provide the Board
with maximum flexibility to raise capital to assist with ongoing funding requirements of the Company,
including executing its growth plans in key international markets.
5
Any placement of the New Shares will occur as part of the Company’s broader capital raising
endeavours, which will likely involve an offer of shares to the Company’s existing shareholders, either
through a pro rata entitlement offer or a share purchase plan, at a price no higher than the issue
price
for New Shares under the placement.
As at the date of this notice, the Company does not have an indication of the party or parties to whom
the New Shares may be issued pursuant to the proposed further placement capacity, nor does it have
any specific transactions in mind for
the utilisation of the proposed further placement capacity.
The New Shares would represent 22.79% of the total number of shares on issue in the Company as at
the date of this notice (being 163,718,833 ordinary shares). If all of the New Shares were issued, then
based on the total number
of shares on issue in the Company as at the date of this notice, the total
number of shares on issue would increase to 201,030,355.
A worked example showing the dilutionary impact of the issue of the New Shares is as follows:
Example shareholder percentage currently: 5.00%
Example shareholder
percentage if all New Shares are issued: 4.07%
Note that the above does not take into account any additional dilution which may occur if the
Company was to issue further new shares, either before or after the date of the Annual Meeting, in
accordance with other provisions of the NZX
Listing Rules, including under Listing Rule 4.3 (which
permits certain pro rata issues and issues under share purchase plans without shareholder approval)
or under Listing Rule 4.5.1 (which permits the issue of ordinary shares representing up to 15% of the
total number of shares on issue in any 12 month period
without shareholder approval). The Company
currently has capacity to issue up to a further 12.21% of equity securities under Listing Rule 4.5.1,
based on the total number of its shares on issue as at the date of this notice. The Board does not
consider that this current placement capacity will
give the Company flexibility to raise a sufficient level
of capital (in addition to the capital it can raise in accordance with Listing Rule 4.3) to execute its
growth plans.
Requirement for Resolution
Listing Rule 4.1.1 requires that the issue of the New Shares be approved by an ordinary resolution of
the existing shareholders of the Company in accordance with Listing Rule 4.2.1.
Each of the Directors of the Company and their Associated Persons (as defined in the Listing Rules) are
prohibited from voting on this resolution in accordance with Listing Rule 6.3.1, other than where the
vote is cast by
a Director or Associated Person as a proxy or voting representative for a person who is
entitled to vote, and in accordance with the express directions given by that person in the Proxy Voting
Form to vote for or against the resolution.
Consequences if resolution is not approved
If the resolution
to approve the issue of the New Shares is not approved, the Company will seek
alternative funding to assist with financing growth opportunities, and may seek further shareholder
approval in the future by way of a vote at a special meeting or future annual meeting.
Voting by Proxy
Any shareholder
who is entitled to vote at the Annual Meeting may appoint a proxy to attend and
vote on their behalf. A shareholder wishing to appoint a proxy should complete and return the Proxy
Voting Form (enclosed with this Notice of Meeting) in the manner specified on the Proxy Voting Form
6
so that the form is received by Computershare no later than 48 hours before the time for holding the
Annual Meeting (i.e., before 10:00am on 2 November 2024). A proxy need not be a shareholder of
Rua. The Chair of the meeting is willing to act as proxy for any shareholder who may wish to appoint
her for that purpose. The Chair will vote as directed on any resolutions, and intends to vote any
discretionary proxies in accordance with the Board recommendations, being in favour of all
resolutions (to the extent permitted by the NZX Listing Rules and Rua’s constitution). The
Chair is
prohibited from voting any discretionary proxy in respect of Ordinary Resolution 2 (including any
motions from the floor and/or any resolutions put before the meeting to amend Ordinary Resolution
2) in accordance with Listing Rule 6.3.1 and any such discretionary proxy will not be valid.
To direct your proxy
how to vote on the resolutions, you should tick the appropriate box on the Proxy
Voting Form. If you appoint a proxy but do not tick one of the boxes in relation to a resolution, you
will be deemed to have granted your proxy the discretion to cast your votes as he or she decides. In
so doing you acknowledge that the proxy may exercise your right to vote even if he or she has an
interest in the outcome of the resolutions (provided that he or she is not disqualified from voting
under the NZX Listing Rules).
If, in appointing
a proxy, you have inadvertently not named someone to be your proxy, or your named
proxy does not attend the meeting, the Chair of the meeting will be your proxy and will vote in
accordance with your express direction.
If you do not attend the Annual Meeting or appoint a
proxy, then no vote will be exercised in respect
of your shareholding.
Entitlement to Vote
All persons on Rua’s register of shareholders as the holders of shares at 5:00pm on 1 November
2024 will be entitled to vote on the resolutions at this Annual Meeting.
If you have appointed a
proxy to attend the Annual Meeting in your place, you may still observe the
Annual Meeting (but only your proxy may cast your votes).
Any corporation that is a shareholder may appoint a person as its representative to attend the Annual
Meeting and vote on its behalf, in the same manner as that in which it could appoint a proxy. A
corporation wishing to appoint a person must ensure that the representative brings an original of the
notice appointing him or her to the meeting. To assist with administration of the Annual Meeting, Rua
would be grateful if notices appointing representatives
are delivered to Computershare Investor
Services Limited at Private Bag 92119, Auckland 1142 or at corporateactions@computershare.co.nz,
at least 48 hours before the time for the holding of the Annual Meeting (i.e., before 10:00am on
Saturday 2 November 2024).
Voting on all of the resolutions is to be by way of
poll. No persons are restricted from voting on, or
acting as a discretionary proxy in relation to, any of the resolutions referred to in this notice of Annual
Meeting, subject to the voting restrictions noted above in respect of Ordinary Resolution 2.
Results
Following the Annual Meeting, the results will be
posted at www.ruabio.com and on www.nzx.com.
---
Your secure access information
Control Number: CSN/Shareholder Number:
PLEASE NOTE: You will need your CSN/Shareholder Number and postcode or country of residence (if outside New Zealand)
to securely access InvestorVote and then follow the prompts to appoint your proxy and exercise your vote online.
Turn over to complete the form to vote
Proxy/Voting Form
How to Vote on Items of Business
All your securities will be voted in accordance with your directions.
Appointment of Proxy
All shareholders of the Company entitled to attend and vote at the virtual meeting
are entitled to appoint a proxy to attend and vote for them instead. A proxy need
not be a shareholder of Rua. The Chair of the meeting is willing to act as proxy for
any shareholder who may wish to appoint them for that purpose. The Chair will
vote as directed on any resolutions, and intends to vote any discretionary proxies
in accordance with the Board recommendations, being in favour of all resolutions
(to the extent permitted by the NZX Listing Rules and Rua’s constitution).
Voting on your holding
To direct your proxy how to vote on the resolutions, you should tick the
appropriate box on the Proxy Voting Form. If you appoint a proxy but do not tick
one of the boxes in relation to a resolution, you will be deemed to have granted
your proxy the discretion to cast your votes as he or she decides. In so doing you
acknowledge that the proxy may exercise your right to vote even if he or she
has an interest in the outcome of the resolutions (provided that interest does not
disqualify him or her from voting under the NZX Listing Rules).
A proxy is able to vote on motions from the floor and/or any resolutions put
before the meeting to amend the resolutions stated in this form unless he or she
is disqualified from voting under the NZX Listing Rules.
If, in appointing a proxy, you have inadvertently not named someone to be your
proxy, or your named proxy does not attend the meeting, the Chair of the meeting
will be your proxy and will vote in accordance with your express direction.
Voting Restrictions
Each of the Directors of the Company and their Associated Persons (as defined in
the Listing Rules) are prohibited from voting on resolution 2 in accordance with
Listing Rule 6.3.1, other than where the vote is cast by a Director or Associated
Person as a proxy or voting representative for a person who is entitled to vote,
and in accordance with the express directions given by that person in the Proxy
Voting Form to vote for or against the resolution.
Attending the Virtual Meeting
All shareholders will have the option to attend, vote and participate in the Annual
Shareholder Meeting online via an internet connection using a laptop, tablet or
smartphone. For further details see the Virtual Meeting Guide that accompanies
this form. If a representative of a corporate security holder or proxy is to attend
the virtual Meeting, they may need to provide evidence of your authorisation to
act prior to admission.
If a shareholder has appointed a proxy, they may attend the virtual meeting but
will not be able to vote.
Signing Instructions for Postal Forms
Individual
Where the holding is in one name, the shareholder must sign.
Joint Holding
Where the holding is in more than one name, all of the shareholders
should sign.
Power of Attorney
If this Proxy Form has been signed under a power of attorney, a copy of the
power of attorney (unless already deposited with the Company) and a signed
certificate of non-revocation of the power of attorney must be produced to the
Company with this Proxy Form.
Companies
This form should be signed by a Director jointly with another Director, or a
Sole Director can also sign alone. Please sign in the appropriate place and
indicate the office held.
Comments & Questions
If you have any comments or questions for the company, please write them
on a separate sheet of paper and return with this form.
Lodge your Proxy
Online
www.investorvote.co.nz
By Mail
Computershare Investor Services Limited
Private Bag 92119, Auckland 1142, New Zealand
By Email
corporateactions@computershare.co.nz
For all enquiries contact
+64 9 488 8777
corporateactions@computershare.co.nz
Lodge your proxy online, 24 hours a day, 7 days a week:
www.investorvote.co.nz
Scan the QR code to vote now.
Smartphone?
For your proxy to be effective it must be received by 10.00am on Saturday, 2nd November 2024.
The 2024 Annual Meeting of Rua Bioscience Limited will be held at 10.00am (New Zealand time)
on Monday, 4th November 2024 online via Computershare Investor Services Limited’s meeting
platform https://meetnow.global/nz.
Proxy/Voting Form
Appoint a Proxy to Vote on Your Behalf
STEP 1
hereby appointof
or failing him/herof
as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions at the Annual General Meeting of
Rua Bioscience Ltd to be held virtually through the Computershare online meeting platform https://meetnow.global/nz on Monday, 4th November 2024 at
10.00am and at any adjournment of that meeting.
I/We being a shareholder/s of Rua Bioscience Ltd
Items of Business - Voting Instructions/Ballot Paper
STEP 2
Please note: In the event I/we have not expressed any intention or the intention is unclear (in my/our proxy’s sole opinion),my/our proxy will vote as
they see fit.
Signature of Shareholder(s) This section must be completed.
SIGN
or Sole Director/Director
Shareholder 1Shareholder 2Shareholder 3
Contact Name Contact Daytime Telephone Date
Ordinary Resolutions
1.
That the Board be authorised to fix the auditor’s remuneration.
2.
That the Directors are authorised to issue up to 37,311,522 new ordinary fully paid shares in the
Company (New Shares) on the following terms:
(a) The New Shares may be issued to any person subject to the Company complying with the
requirements of the Financial Markets Conduct Act 2013 and the NZX Listing Rules in relation to
any such issue.
(b) The New Shares may be issued through a single placement of up to 37,311,522 New Shares or via
separate placements of up to 37,311,522 New Shares in aggregate.
(c) Each New Share shall be issued at an issue price of not less than $0.03.
(d) The New Shares may be issued at any time during the course of the 12 month period following the
passing of this resolution.
(e) The New Shares, when issued, shall rank pari passu (equally) with all existing ordinary shares in
the Company.
For
Against
Abstain
Proxy
Discretion
or Director (if more than one)
If your proxy is not the Chairman of the Meeting or any other director of the Company, please ensure that you provide their contact details (phone
and email address). If this information is not provided, we cannot guarantee remote admission to the virtual meeting for your proxy.
Proxy contact Details (Phone): and (Email):
---
Attending the meeting online
Our online meeting provides you the opportunity to
participate online using your smartphone, tablet or computer.
If you choose to attend online you will be able to view a live
webcast of the meeting, ask questions and submit your
votes in real time.
You
will need the latest version of Chrome, Safari or
Edge. Please ensure your browser is compatible.
HOW TO PARTICIPATE IN VIRTUAL/HYBRID MEETINGS
Visit https://meetnow.global/nz
When successfully authenticated, the home screen
will be displayed. You can watch the webcast, vote,
ask questions, and view meeting materials in the
documents folder. The image highlighted blue
indicates the page you have active.
The webcast will appear and begin automatically
once the meeting has started.
Voting
Resolutions will be put forward once voting is
declared open by the Chair. Once the voting has
opened, the resolution and voting options will appear.
To vote, simply select your voting direction from the
options shown on screen. You can vote for all
resolutions at once or by each resolution.
Your vote has been cast when the green tick appears.
To change your vote, select ‘Change Your Vote’.
Q&A
Any eligible shareholder/proxy attending the meeting
r
emotely is eligible to ask a question.
S
elect the Q&A tab and type your question into the
box at the bottom of the screen and press 'Send'.
Navigation
Access
Access the online meeting at
https://meetnow.global/nz, and select the required
meeting. Click 'JOIN MEETING NOW'.
If you are a shareholder:
Select 'Shareholder' on the login screen and enter
your CSN/Holder Number and Post Code. If you are
outside New Zealand, simply select your country
from the drop down box instead of the post code.
Accept the Terms and Conditions and click Continue.
If you are a guest:
Select Guest on the login screen. As a guest, you will
be prompted to complete all the relevant fields
including title, first name, last name and email
address.
Please note, guests will not be able to ask questions
or vote at the meeting.
If you are a proxy holder:
You will receive an email invitation the day before the
meeting to access the online meeting. Click on the
link in the invitation to access the meeting.
Contact
If you have any issues accessing the website please
c
all +64 9 488 8700.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.